New treatments for fat reduction and metabolic health are producing exhilaration inside the clinical Neighborhood, and on the list of promising names is Retatrutide. Sadly, the dosing protocols in these phase 3 trials are usually not but published, although the probably protocol to be used will most likely entail the next dosing regime: I